ADGRB1 and glioblastoma: Both the first generation oHSV, RAMBO (rapid antiangiogenesis mediated by oncolytic virus), and the second generation oHSV, 34.5ENVE (viral ICP34.5 expressed by nestin promotor and Vstat120 expressing), were shown to have therapeutic efficacy in GBM models [59,60].